Ono Pharmaceutical Co., Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ono Pharmaceutical Co., Ltd.'s balance sheet done over the years? Its assets were worth $913,668,000,000 last year, which is more than in the previous period. 13% of Ono Pharmaceutical Co., Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $115,063,000,000, which means an decrease by -15% compared compared to last year.
Debt to Assets
| 2015 | 524588000000 | 49.37B | 9.41% |
|---|---|---|---|
| 2016 | 540450000000 | 64.19B | 11.88% |
| 2017 | 617461000000 | 93.25B | 15.1% |
| 2018 | 609226000000 | 79.60B | 13.07% |
| 2019 | 655056000000 | 92.32B | 14.09% |
| 2020 | 673444000000 | 105.42B | 15.65% |
| 2021 | 746842000000 | 105.68B | 14.15% |
| 2022 | 739203000000 | 77.52B | 10.49% |
| 2023 | 882437000000 | 134.62B | 15.26% |
| 2024 | 913668000000 | 115.06B | 12.59% |
OPHLF Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 166.14B | 96.13B | 69.11B | 61.04B | 69.00B | 59.98B | 65.27B | 146.32B | 110.48B | 104.22B |
Short term investments | 38.45B | 68.15B | 47.85B | 43.93B | 31.41B | 11.48B | 20.50B | 18.37B | 22.38B | 23.56B |
Net receivables | 136.06B | 114.39B | 99.78B | 84.26B | 76.83B | 76.28B | 77.57B | 73.25B | 62.04B | 41.96B |
Inventory | 48.62B | 44.81B | 41.81B | 39.15B | 32.90B | 32.82B | 31.29B | 25.33B | 23.23B | 25.80B |
Other current assets | 62.76B | 89.73B | 22.69B | 19.24B | 15.06B | 14.04B | 14.82B | 8.56B | 5.43B | 3.13B |
Total current assets | 413.59B | 345.10B | 281.26B | 247.64B | 225.22B | 194.61B | 209.46B | 271.03B | 223.57B | 197.86B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 104.75B | 108.42B | 112.13B | 113.86B | 114.62B | 108.87B | 94.32B | 83.65B | 80.09B | 70.75B |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 57.28B | 69.13B | 64.73B | 70.32B | 66.43B | 63.05B | 55.71B | 45.23B | 38.32B | 33.91B |
Long term investments | 297.17B | 252.71B | 204.59B | 234.86B | 198.05B | 251.77B | 215.10B | 185.14B | 167.74B | 195.93B |
Other non-current assets | 40.86B | 71.46B | 51.39B | 46.52B | 34.28B | 15.65B | 24.43B | 21.64B | 25.53B | 26.07B |
Total non-current assets | 500.07B | 537.33B | 457.93B | 499.2B | 448.22B | 460.43B | 399.76B | 346.42B | 316.87B | 326.72B |
Total assets | 913.66B | 882.43B | 739.20B | 746.84B | 673.44B | 655.05B | 609.22B | 617.46B | 540.45B | 524.58B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 35.23B | 2.24B | 40.38B | 41.51B | 33.70B | 24.19B | 36.67B | 11.00B | 9.85B |
Short term debt | 2.31B | -32.74B | 2.30B | 2.02B | 2.18B | 435M | 392M | 820M | 328M | 522M |
Total current liabilities | 103.62B | 122.92B | 65.92B | 93.73B | 91.32B | 83.15B | 68.46B | 82.93B | 52.19B | 34.99B |
| Non-current liabilities: | ||||||||||
Long term debt | 6.55B | 6.67B | 6.50B | 7.03B | 6.17B | 1.76B | 320M | 1.08B | 515M | 633M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 4.88B | 1.66B | 771M | 814M | 813M | 832M | 4.70B | 9.23B | 4.78B | 13.74B |
Total non-current liabilities | 11.43B | 11.69B | 11.60B | 11.95B | 14.09B | 9.17B | 11.13B | 10.31B | 12.00B | 14.37B |
Total liabilities | 115.06B | 134.62B | 77.52B | 105.68B | 105.42B | 92.32B | 79.60B | 93.25B | 64.19B | 49.37B |